Eupantol and haemoglobin decreased Patient Reports February 13, 2012

Eupantol Side Effects Report #4743942-X
Eupantol side effect was reported by a Consumer or non-health professional from FRANCE on July 29, 2005. Female patient, 81 years of age, was treated with Eupantol. After drug was administered, patient experienced the following side effects: coagulation factor v level decreased, cytolytic hepatitis, haemoglobin decreased, hepatic artery thrombosis, hepatic failure, hyperammonaemia, lactic acidosis, platelet count decreased, prothrombin level decreased. Eupantol dosage: 40 MG 1X PER 1 DAY. During the same period patient was treated with CANCIDAS, SYNERCID, TARGOCID. Patient died.

Eupantol Side Effects Report #4765850-0
Eupantol side effect was reported by a Consumer or non-health professional from FRANCE on Aug 24, 2005. Female patient, 81 years of age, was treated with Eupantol. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, haemoglobin decreased, hepatic artery thrombosis, hepatic failure, hyperammonaemia, lactic acidosis, platelet count decreased, renal failure. Eupantol dosage: 40 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CANCIDAS, SYNERCID, TARGOCID. Patient was hospitalized. Patient died.

Eupantol Side Effects Report #5192177-8
Eupantol side effect was reported by a Consumer or non-health professional from FRANCE on Dec 07, 2006. Male patient, 62 years of age, was treated with Eupantol. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, condition aggravated, gastric ulcer, haemoglobin decreased, hydronephrosis, intestinal dilatation, metastases to peritoneum, metastatic neoplasm. Eupantol dosage: 40 MG 1X PER 1 DAY; INTRAVENOUS; 40 MG 1X PER 1 DAY' INTRAVENOUS. During the same period patient was treated with RANITIDINE HYDROCHLORIDE, LOVENOX, PERFALGAN. Patient was hospitalized. Patient died.

Eupantol Side Effects Report #4801149-1
Eupantol side effect was reported by a Consumer or non-health professional from FRANCE on Sept 29, 2005. Female patient, 52 years of age, was diagnosed with prophylaxis, cardiac failure and was treated with Eupantol. After drug was administered, patient experienced the following side effects: agranulocytosis, haemoglobin decreased, haemorrhage, histiocytosis haematophagic, pneumonia , respiratory distress. Eupantol dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, DIGOXIN, DIPRIVAN, TAZOCILLINE, ULTIVA, DOBUTREX, EPINEPHRINE, NORADRENALINE. Patient recovered.